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Alzheimer’s disease (AD) is the most common form of
dementia among older people. It is characterized by the
extracellular  accumulation of 
 
 
 
-amyloid (A
 
 
 
) deposits
called senile or neuritic plaques. A
 
 
 
 is generated by the
proteolytic cleavage of A
 
 
 
 precursor protein (APP) by 
 
 
 
and 
 
 
 
-secretases localized in the secretory and endocytic
compartments. In this issue, Yu et al. (on p. 87) report
a novel mechanism for the generation of A
 
 
 
 peptides,
which takes place in autophagic vacuoles (AVs) that accu-
mulate in AD brains.
 
Autophagy is a generic term for pathways that transport cyto-
solic contents to lysosomes. Three types of autophagy have
been proposed: macroautophagy, microautophagy, and chaper-
one-mediated autophagy (Cuervo, 2004; Levine and Klionsky,
2004). Among these, macroautophagy is believed to be respon-
sible for the majority of intracellular protein degradation.
When macroautophagy (hereafter simply referred to as autoph-
agy) is induced by nutrient starvation and other stresses or
chemical agents, cytoplasmic constituents, including organelles,
are enclosed by membrane cisternae known as isolation mem-
branes (Fig. 1). Closure of these membranes results in the for-
mation of double membrane structures called autophagosomes.
The autophagosomes eventually fuse with lysosomes to be-
come autolysosomes. Lysosomal hydrolases degrade the cyto-
plasm-derived contents of the autophagosome together with its
inner membrane. The primary role of autophagy is adaptation
to nutrient starvation; autophagy is extensively induced after
food withdrawal (Mizushima et al., 2004) and during the early
neonatal period (Kuma et al., 2004). Besides this fundamental
role, autophagy plays pleiotropic roles in intracellular clear-
ance, degradation of invading bacteria, antigen presentation,
and possibly cell death (Debnath et al., 2005). In addition, the
relationship of autophagy to various diseases is now attracting
attention.
The accumulation of AVs or related structures has been re-
ported in several human diseases. Intriguingly, the list includes
typical neurodegenerative diseases, including AD (Okamoto et
al., 1991; Cataldo et al., 1996), polyglutamine (CAG repeat)
diseases (Petersen et al., 2001; Ravikumar et al., 2002), and
Parkinson’s disease (Anglade et al., 1997). It should be noted
that autophagic activity is maintained at low levels in the brain
even with nutrient starvation, which is a condition that induces
autophagy in most other organs (Mizushima et al., 2004). Thus,
neural cells have the ability to induce autophagy in response to
factors other than nutrient limitation.
It has been suggested that autophagy may be upregulated
to eliminate abnormal intracellular proteins that would otherwise
accumulate within cells as aggregates or inclusions (Ravikumar
et al., 2004). In addition, it was recently shown that protein ag-
gregates accumulate extensively in the hepatocytes of liver-
specific Atg7 knockout mice without the expression of mutant
proteins, suggesting that autophagy indeed plays a critical role
in intracellular clearance (Komatsu et al., 2005).
In contrast, there is an opposing idea that continuous
autophagy might promote cell death; however, this is still a
controversial issue (Debnath et al., 2005). It has been shown
that autophagy is induced in certain types of cell death (mainly
nonapoptotic), but only a limited number of studies have dem-
onstrated that autophagy is required for cell death (Shimizu et
al., 2004; Yu et al., 2004). Most cell death that is associated
with autophagy may not be caused by the activation of autoph-
agy (Degterev et al., 2005).
In this issue, Yu et al. (2005) report a novel role of au-
tophagy in the pathogenesis of AD. They have shown that AVs
accumulate in the brains of AD patients and presenilin-1 (PS1)/
APP mice, which is an AD model in which both human mutant
PS1 and mutant APP are expressed. A large number of AVs
were observed in dystrophic neurites before the appearance of
extracellular A
 
 
 
 deposition, indicating that AV accumulation
is a very early event. In contrast to the larger number of AVs,
the increase in dense bodies (dense lysosomes) was much
smaller. Accordingly, they have concluded that there is an
impairment of autolysosome maturation into lysosomes in the
AD brain (Fig. 1).
Furthermore, Yu et al. (2005) found not only that AVs
accumulate in AD neurons but also that A
 
 
 
 is produced within
the AVs. First, they detected A
 
 
 
 peptides (both A
 
 
 
40 and
A
 
 
 
42) and 
 
 
 
-secretase complex components such as PS1 and
nicastrin on the membranes of and inside AVs in the brains of
AD patients, AD model mice, and several cell lines expressing
APP. By cell fractionation analysis, they confirmed that these
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proteins were highly enriched in AVs. Second, they observed a
clear correlation between autophagic activity and A
 
 
 
 secretion
into the medium. When autophagy was upregulated in cell lines
by amino acid starvation or mammalian target of rapamycin
inhibition, A
 
 
 
 generation was accelerated. In contrast, A
 
 
 
generation was suppressed when autophagy was inhibited by
3-methyladenine or an excess of amino acids. Finally, they
detected PS1-dependent 
 
 
 
-secretase activity in isolated AV
fractions. Under normal growth conditions, the highest
 
 
 
-secretase activity was detected in the ER/Golgi/endosome
fraction. However, the highest 
 
 
 
-secretase activity was de-
tected in AVs when autophagy was induced by starvation. Al-
together, Yu et al. (2005) propose that AVs are a novel site of
A
 
 
 
 peptide production.
The idea that persistent and/or incomplete autophagic
degradation participates in the excess production of A
 
 
 
 pep-
tides is very attractive. The findings of Yu et al. (2005) raise
several issues that merit further investigation. Can A
 
 
 
 pep-
tides that are produced in AVs be efficiently secreted into the
extracellular space and contribute to plaque formation? It is
currently thought that the lysosome is not a terminal organelle
and that lysosomal contents can be secreted through exocyto-
sis or exosome-mediated secretion. How are APP/A
 
 
 
 and the
 
 
 
-secretase complex incorporated into AVs? Because PS1 is
detected on the limiting membrane of AVs (Yu et al., 2005),
PS1 might be recruited on the source membrane of autophago-
somes. In addition, as ER fragments are frequently seques-
tered into autophagosomes (Hamasaki et al., 2005), APP and
the 
 
 
 
-secretase complex might be engulfed together with ER
fragments as substrates (Fig. 1). Golgi apparatus containing
APP and secretases also could be sequestered by autophago-
somes. Alternatively, these proteins may be delivered to endo-
somes and lysosomes via the conventional secretory pathway
and may then join the autophagic pathway upon AV–lyso-
some fusion. Is A
 
 
 
 in AVs toxic for cells? It has been reported
that the number of extracellular plaques does not correlate
with AD symptoms, whereas intracellular A
 
 
 
 is toxic to neu-
rons (Billings et al., 2005). The final, and probably most im-
portant, question is to determine what primarily causes the
AV maturation defect in AD. This question may well be re-
lated to the question of why APP is specifically processed into
A
 
 
 
 instead of being completely degraded to amino acids by
lysosomal proteases.
In general, little is known about the involvement of au-
tophagy in neurodegenerative diseases. However, the new data
reported by Yu et al. (2005) provides new insights into the role
of AVs and the mechanism of A
 
 
 
 generation in AD.
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Figure 1. A  production in AVs. The membrane dynamics
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the AD brain are depicted. A portion of cytoplasm is en-
closed by the isolation membrane to form an autophago-
some. The outer membrane of the autophagosome then
fuses with a lysosome to degrade the inside materials.
Organelles can be degraded by this pathway. After diges-
tion is completed, autolysosomes are thought to become
dense lysosomes. The origin of the isolation membrane is
not known, but vesicles might be delivered from the ER.
Thus, APP and the  -secretase complex could be incorpo-
rated into the autophagosome membrane. Alternatively,
ER and the Golgi apparatus containing APP and the
 -secretase complex may be engulfed by autophago-
somes. In AD, some steps of autophagosome/autolysosome
maturation are blocked, which may promote A  production. 
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